Literature DB >> 23047515

From small nodule to overt HCC: a multistep process of carcinogenesis as seen during surveillance.

E Rinninella1, M A Zocco, A De Gaetano, R Iezzi, M Campanale, V Cesario, F Barbaro, F R Ponziani, G Caracciolo, S Triarico, A Tortora, G Ianiro, A Gasbarrini.   

Abstract

BACKGROUND: Hepatocellular carcinoma (HCC) is the third most common cause of cancer-related death in the world. Despite many diagnostic and therapeutic tools are now available to improve survival and reduce its recurrence, prognosis is closely conditioned by the time of diagnosis. Surveillance and early diagnosis are crucial for a successful therapy. We report a clinical case from the HCC archive of the Hepatocatt meetings held in Ge-melli Hospital (Catholic University of Rome). The case describes a tumor progression in a multistep process from a small liver nodule to overt HCC and its management by a multidisciplinary team.

Entities:  

Mesh:

Year:  2012        PMID: 23047515

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  6 in total

Review 1.  Joint Consensus Statement of the Indian National Association for Study of the Liver and Indian Radiological and Imaging Association for the Diagnosis and Imaging of Hepatocellular Carcinoma Incorporating Liver Imaging Reporting and Data System.

Authors:  Sonal Krishan; Radha K Dhiman; Navin Kalra; Raju Sharma; Sanjay S Baijal; Anil Arora; Ajay Gulati; Anu Eapan; Ashish Verma; Shyam Keshava; Amar Mukund; S Deva; Ravi Chaudhary; Karthick Ganesan; Sunil Taneja; Ujjwal Gorsi; Shivanand Gamanagatti; Kumble S Madhusudan; Pankaj Puri; Shallini Govil; Manav Wadhavan; Sanjiv Saigal; Ashish Kumar; Shallini Thapar; Ajay Duseja; Neeraj Saraf; Anubhav Khandelwal; Sumit Mukhopadyay; Ajay Gulati; Nitin Shetty; Nipun Verma
Journal:  J Clin Exp Hepatol       Date:  2019-08-06

2.  TACE with degradable starch microspheres (DSM-TACE) as second-line treatment in HCC patients dismissing or ineligible for sorafenib.

Authors:  Roberto Iezzi; Maurizio Pompili; Emanuele Rinninella; Eleonora Annicchiarico; Matteo Garcovich; Lucia Cerrito; Francesca Ponziani; AnnaMaria De Gaetano; Massimo Siciliano; Michele Basso; Maria Assunta Zocco; GianLodovico Rapaccini; Alessandro Posa; Francesca Carchesio; Marco Biolato; Felice Giuliante; Antonio Gasbarrini; Riccardo Manfredi
Journal:  Eur Radiol       Date:  2018-08-31       Impact factor: 5.315

3.  Characterization of microvessels and parenchyma in in-line phase contrast imaging CT: healthy liver, cirrhosis and hepatocellular carcinoma.

Authors:  Jinghao Duan; Chunhong Hu; Qingtao Qiu; Jing Zhang; Huipeng Meng; Keqiang Wang; Huajiang Dong; Hong Wei; Yong Yin
Journal:  Quant Imaging Med Surg       Date:  2019-06

Review 4.  The role of the dysfunctional akt-related pathway in cancer: establishment and maintenance of a malignant cell phenotype, resistance to therapy, and future strategies for drug development.

Authors:  Gaetano Romano
Journal:  Scientifica (Cairo)       Date:  2013-12-05

5.  Identification of key candidate genes and pathways in hepatocellular carcinoma by integrated bioinformatical analysis.

Authors:  Tonghai Xing; Tingmang Yan; Qiang Zhou
Journal:  Exp Ther Med       Date:  2018-04-16       Impact factor: 2.447

6.  Identification and Validation of Hub Genes with Poor Prognosis in Hepatocellular Carcinoma by Integrated Bioinformatical Analysis.

Authors:  Jiang Guo; Wei Li; Long Cheng; Xuesong Gao
Journal:  Int J Gen Med       Date:  2022-04-11
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.